Announcement of the 2021 consolidated financial report approved by the Board of Directors
· Issued by Taiyen Biotech Co. Ltd.
Close
Today's Information
Provided by: Taiyen Biotech Co.,Ltd
SEQ_NO
3
Date of announcement
2022/03/18
Time of announcement
16:09:26
Subject
Announcement of the 2021 consolidated financial
report approved by the Board of Directors
Date of events
2022/03/18
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/03/18
2.Date of approval by the audit committee:2022/03/18
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):2021/01/01~2021/
12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):4,095,651
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):1,373,236
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):529,177
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):509,918
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):412,162
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):393,227
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):1.97
11.Total assets end of the period (thousand NTD):8,467,640
12.Total liabilities end of the period
(thousand NTD):1,954,263
13.Equity attributable to owners of parent end of the
period (thousand NTD):6,361,174
14.Any other matters that need to be specified:None
